Agmatine ameliorates manifestation of depression-like behavior and hippocampal neuroinflammation in mouse model of Alzheimer’s disease

@article{Kotagale2020AgmatineAM,
  title={Agmatine ameliorates manifestation of depression-like behavior and hippocampal neuroinflammation in mouse model of Alzheimer’s disease},
  author={Nandkishor R Kotagale and R. D. Deshmukh and Madhura P. Dixit and Rajshree Fating and Milind Janraoji Umekar and Brijesh Gulabrao Taksande},
  journal={Brain Research Bulletin},
  year={2020},
  volume={160},
  pages={56-64}
}
Agmatine as a novel candidate for rapid-onset antidepressant response
TLDR
Evidence is sought about the mechanisms that may underlie the fast antidepressant-like responses of agmatine in preclinical studies and whether it may be investigated as a useful compound for the management of MDD associated with a pro-inflammatory state.
A New Potential Antidepressant: Dexmedetomidine Alleviates Neuropathic Pain-Induced Depression by Increasing Neurogenesis in the Hippocampus
TLDR
DEX dose-dependently alleviates depression induced by chronic pain through neurogenesis promotion in the DG region of the hippocampus and shows that 25 µg/kg DEX had the best promotion effect during increased sucrose preference and reduced immobility time.
Limonene through Attenuation of Neuroinflammation and Nitrite Level Exerts Antidepressant-Like Effect on Mouse Model of Maternal Separation Stress
TLDR
It is concluded that the antidepressant-like effects of limonene are probably mediated through inhibition of neuroinflammation and attenuation of nitrite levels in the hippocampus.
Effects of imidazoline agents in a rat conditioned place preference model of addiction
TLDR
Assessment of the interaction between AG, IDZ, and EFR with an opiate, tramadol, in a conditioned place preference (CPP) paradigm found that AG reversed the TR-induced CPP, while EFR and IDZ only decreased the time spent in theTR-paired compartment, without statistical significance.

References

SHOWING 1-10 OF 57 REFERENCES
Minocycline prevents the development of depression-like behavior and hippocampal inflammation in a rat model of Alzheimer’s disease
TLDR
These findings support the idea that there is a significant relationship among AD, depression-related symptoms, and pro-inflammatory cytokines in the brain, and suggest that antidepressant-like impacts of minocycline could be due to its anti-inflammatory properties.
Amyloid-β oligomers link depressive-like behavior and cognitive deficits in mice
TLDR
The results indicate that AβOs have an acute impact on memory, learning and mood in mice, and that fluoxetine treatment prevented both cognitive impairment and depressive-like behavior induced by A βOs.
Involvement of the agmatinergic system in the depressive-like phenotype of the Crtc1 knockout mouse model of depression
TLDR
Findings implicate Agmat in the depressive-like phenotype of Crtc1−/− mice, refine current understanding of the agmatinergic system in the brain and highlight its putative role in major depression.
Antidepressant drugs for beta amyloid-induced depression: A new standpoint?
Agmatine, by Improving Neuroplasticity Markers and Inducing Nrf2, Prevents Corticosterone-Induced Depressive-Like Behavior in Mice
TLDR
The present results reinforce the participation of Nrf2 in the antidepressant-like effect produced by agmatine and expand literature data concerning its mechanisms of action.
...
1
2
3
4
5
...